The influencer ‘Roaring Kitty’ shook the stock markets with the ‘meme stock’ phenomenon, with GameStop, Inc. (NYSE: GME) becoming his most notable trade. Meme stocks have generated substantial wealth for traders, and it seems Roaring Kitty is now broadening his scope. This feature offers insight into the stock’s worth monitoring in light of Roaring Kitty’s latest moves.

Chewy Inc. (NASDAQ: CHWY): Chewy experienced significant volatility on July 1 after a regulatory filing revealed that Roaring Kitty acquired a 6.6% stake. Roaring Kitty bought 9 million shares of the pet retailer, totaling over $261 million at a closing price of $29.05 per share on June 28. This made him the third-largest shareholder, with the stock gaining over 20% before markets opened on July 1. 

Dyadic International Inc. (NASDAQ: DYAI): Dyadic International, a leader in cell culture solutions, announced a strategic partnership with Proliant Health and Biologicals (PHB) last month. PHB will provide $1.5 million upfront for developing high-volume, cost-effective cell culture products set to enter the $6 billion serum albumin market in the first half of 2025. Zacks SmallCap valued Dyadic at $9 a share in a July 1 report. Read entire report now. 

Petco Health and Wellness Company Inc. (NASDAQ: WOOF): Petco released its 2023 ESG report last month, highlighting its commitment to pet owners, pets, and employees. The Petco Love initiative found homes for 142,924 pets in the 2023 fiscal year and donated $33.5 million to 2,000 animal welfare organizations and shelters. Petco also expanded its in-store veterinary hospitals to over 280 locations. 

Catheter Precision Inc. (NYSE AMERICAN: VTAK) saw its stock surge 43.58% on July 1, reaching an intraday high of $0.84 per share before pulling back over 50% to $0.38, creating a potential buying opportunity. This followed the announcement of unaudited revenues for the fiscal quarter and six months ended June 30, 2024. The company reported sales of its innovative LockeT and VIVO products. The VIVO system, a non-invasive 3D imaging technology, enhances the efficiency of ventricular ablation, aligning with the company’s expansion strategy. Read Entire Update Now!

Catheter Precision Inc. (NYSE AMERICAN: VTAK) saw its stock surge 43.58% on July 1, reaching an intraday high of $0.84 per share before pulling back over 50% to $0.38, creating a potential buying opportunity. This followed the announcement of unaudited revenues for the fiscal quarter and six months ended June 30, 2024. The company reported sales of its innovative LockeT and VIVO products. The VIVO system, a non-invasive 3D imaging technology, enhances the efficiency of ventricular ablation, aligning with the company’s expansion strategy. Read Entire Update Now!

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com